发明名称 |
RBM3 PROTEIN IN TESTICULAR CANCER DIAGNOSTICS AND PROGNOSTICS |
摘要 |
<p>The present disclosure provides a method for determining whether a mammalian subject belongs to a first or a second group, wherein subjects of the first group have a higher risk of having a testicular disorder than subjects of the second group, comprising the steps of: evaluating an amount of RBM3 protein in at least part of an earlier obtained sample comprising biological material from a testicle of said subject and determining a sample value corresponding to the evaluated amount; comparing said sample value with a predetermined reference value; and if said sample value is higher than said reference value, concluding that the subject belongs to the first group; and if said sample value is lower than or equal to said reference value, concluding that the subject belongs to the second group. Further, a prognostic method for testicular cancer is provided, as well as means and uses with prognostic and diagnostic applications.</p> |
申请公布号 |
WO2010092187(A1) |
申请公布日期 |
2010.08.19 |
申请号 |
WO2010EP51935 |
申请日期 |
2010.02.16 |
申请人 |
ATLAS ANTIBODIES AB;JIRSTROEM, KARIN;EBERHARD, JAKOB |
发明人 |
JIRSTROEM, KARIN;EBERHARD, JAKOB |
分类号 |
G01N33/574;G01N33/68 |
主分类号 |
G01N33/574 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|